JOSE MARIA
HERRERAS CANTALAPIEDRA
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
![Foto de JOSE MARIA](/img/nophoto.png)
![Foto de Hospital Clinic Barcelona](/img/noimage_org.png)
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (9)
2023
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
2020
-
Recommendations statement on the immunosuppressive treatment of non-infectious, non-neoplastic, non-anterior uveitis
Medicina Clinica, Vol. 155, Núm. 5, pp. 220.e1-220.e12
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2017
-
Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis
Medicine (United States), Vol. 96, Núm. 42
-
Treatment recommendations for non-infectious anterior uveitis
Medicina Clinica, Vol. 149, Núm. 12, pp. 552.e1-552.e12
2015
-
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 3, pp. 361-368